Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5872 posts found.

gilead-sciences

Gilead buys Novartis’ herpes, flu and cold virus preclinical programmes

July 23, 2019 Manufacturing and Production Gilead, Novartis, antivrial, deal, herpes, influenza, rhinovirus

Gilead has acquired the rights to three of Novartis’ preclinical antiviral programmes, including investigational compounds with the potential to treat …
News
bottle_of_lies_3d_bookshot_w_logo_

Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world

July 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Contamination, FDA, India, chin, compliance, manufacturing, pharma, regulation, valsartan

The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma

On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …
News
johnmchutchison3x

Dr John McHutchinson steps down from Gilead with $1.1 million goodbye

July 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead has said that Dr John McHutchison is stepping down after nine years at the firm. Gilead’s Chief Scientific Officer …
Appointment
shutterstock_114045100

“Little to no progress” made in achieving gender representation within top pharma firms, report says

July 18, 2019 Manufacturing and Production, Medical Communications female representation, gender equality, pharma

The release of Women Count 2019, an annual report funded by The Pipeline, has revealed that “little to no progress” …
News

NICE greenlights Novartis Kisqali combo in HR+/HER2- advanced breast cancer

July 17, 2019 Manufacturing and Production, Medical Communications, Research and Development Cancer, Kisqali, NICE, Novartis, UK, breast cancer, pharma

Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (CDK4/6) …
News
Bayer image

Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients

July 16, 2019 Manufacturing and Production, Sales and Marketing Bayer, FDA, Gadavist, coronary artery disease, pharma

The FDA has awarded approval to Bayer’s Gadavist (gadobutrol) injection, the company confirmed.
News
shutterstock_159488225

Capricor’s share price rockets up by 150% on Phase 2 Duchenne muscular dystrophy success

July 16, 2019 Manufacturing and Production, Research and Development CAP-1002, Capricor Therapeutics, Duchenne Muscular Dystrophy, pharma

Capricor Therapeutics has unveiled impactful new Phase 2 data for its investigational allogeneic cardiosphere-derived cell therapy CAP-1002 in the treatment …
News

Oklahoma lawyers say J&J is kingpin of pharmaceutical cartel

July 16, 2019 Manufacturing and Production J&J, JJ, Oklahoma, opioid crisis, opioids, pharma

Lawyers representing the State of Oklahoma described Johnson & Johnson as the ‘kingpin’ in a ‘pharmaceutical cartel’ as they accused …
News

GSK teams up with Strathclyde and University of Nottingham

July 16, 2019 Manufacturing and Production GSK, GlaxoSmithKline, UK, britain, pharma, universities

GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at …
News
boehringer_biberach_germany_copy

Boehringer buys cancer vaccine company AMAL Therapeutics for €325 million

July 16, 2019 Manufacturing and Production AMAL Therapeutics, Boehringer Ingelheim, Geneva, cancer vaccines, oncology

Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines. AMAL’s lead candidate, …
News
darius_hughes

Darius Hughes, Head of Vaccines Business Unit UK, Pfizer

July 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Darius Hughes, Pfizer, Working Life, biotech, pharma, vaccines

“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines

This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …
News
dr_kim_branson

GSK hires computational drug design expert Dr Kim Branson as new head of machine learning and AI

July 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President, Global …
Appointment
epipen

Novartis aims to solve EpiPen shortage with generic launch of Symjepi to US pharmacies

July 10, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Novartis, Sandoz, US, epipen, pharma

Novartis has announced the immediate availability of its generic epinephrine auto-injector in pharmacies throughout the US, as it moves to …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026